RIVANOL 1% ointment 0, 5 g/50 g Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

rivanol 1% ointment 0, 5 g/50 g

ВЕТПРОМ АД - Этакридина лактат - маз за кожа - 0, 5 g/50 g - котки, кучета

SULFATHIAZOL 5 % ointment 2.5 g/50 g Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

sulfathiazol 5 % ointment 2.5 g/50 g

ВЕТПРОМ АД - sulfathiazole натрий - маз за кожа - 2.5 g/50 g - говеда, кози, коне, котки, кучета, овце, прасета

SULPHATHIAZOLE unguent 5.0 g/100 g Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

sulphathiazole unguent 5.0 g/100 g

ФАРМА ВЕТ ООД - sulfathiazole натрий - маз за кожа - 5.0 g/100 g - агнета, кози, коне, крави, кучета, овце, телета, ярета

TETRACYCLIN 1% OINTMENT 480000 IU/50g Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

tetracyclin 1% ointment 480000 iu/50g

ВЕТПРОМ АД - Тетрациклин хидрохлорид - маз за кожа - 480000 iu/50g - говеда, кози, коне, кучета, овце, свине

TETRAMAST forte syringae intrammariae 10 g Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

tetramast forte syringae intrammariae 10 g

Завет АД - Тетрациклин хидрохлорид; сулфат неомицина, бацитрацина, преднизолона ацетат - интрамамарна маз - 200 000 iu; 100 000 iu; 2000 iu; 0.0100 g/10 g - крави

Arsenic trioxide medac Uni Eropa - Bulgar - EMA (European Medicines Agency)

arsenic trioxide medac

medac gesellschaft für klinische spezialpräparate mbh - Арсеник Триоксид - Левкемия, промиелоцитна, остра - Антинеопластични средства - arsenic trioxide medac is indicated for induction of remission, and consolidation in adult patients with:newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 10³/μl) in combination with all-trans-retinoic acid (atra)relapsed/refractory apl (previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rarα) gene. Скоростта на реакция друг остър миелобластный подтипове на левкемия до триоксида арсен не е считан за.

CEFQUIMAST syringe intramammariae 75.0 mg /8 g Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

cefquimast syringe intramammariae 75.0 mg /8 g

Завет АД - cefquinome - интрамамарна маз - 75.0 mg /8 g - говеда

RILEXINE DC 375 mg интрамамарна суспензия за сухостойни крави/ RILEXINE DC 375 mg intramammary suspension for dry cows 375 mg/8 Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

rilexine dc 375 mg интрамамарна суспензия за сухостойни крави/ rilexine dc 375 mg intramammary suspension for dry cows 375 mg/8

virbac - Цефалексина - интрамамрна суспензия - 375 mg/8 g - крави

Zolsketil pegylated liposomal Uni Eropa - Bulgar - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.